Singapore To Tackle Medical Ethics

17 July 1994

Singapore's Health Minister George Yeo has announced that his Ministry has established a national committee to examine ethical issues relating to medical practice and research.

The committee's responsibilities will include identifying existing ethical issues and also monitoring trends in developed countries, in order to be able to advise the Ministry of potential new problems. it will also establish ethical codes of conduct for doctors and examine how medical ethics could be taught to medical students. The Minister also said that the Singapore Medical Council will be empowered to deal with doctors who transgressed these codes.

In order to prevent the practice of medicine being reduced to the level of a trade, and the doctor-patient relationship becoming a mere commercial transaction, he told a meeting of the Medical Alumni Association, there is a need for a strong ethical code plus sanctions and safeguards provided by the Ministry. However, he added, input must also come from within the medical profession, as no sanction is more effective than professional peer pressure. This would also improve the "ethical tone" of the profession, and increase public respect.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight